Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Rosuvastatin Potential treatment - clinical evidence Used to treat other disease Other treatment Dec/20/2021 2 0
Methylprednisolone Potential treatment - clinical evidence Used to treat other disease Other treatment Nov/03/2021 40 4
Ritonavir Emergency use authorization Used to treat other disease Antiviral Nov/02/2021 27 14
Favipiravir Potential treatment - clinical evidence Used to treat other disease Antiviral Sep/24/2021 27 7
Chloroquine phosphate Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/27/2021 25 9
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Apr/27/2021 38 47
Lopinavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/22/2021 26 15
Nafamostat mesylate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/20/2021 12 0
Bictegravir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/18/2021 4 0
Azithromycin Potential treatment - clinical evidence Used to treat other disease Antiviral Feb/26/2021 19 10